This inventor holds 1 USPTO granted patent. Top assignees: Children's Medical Center Corporation, University of California. Active years: 2025.
Company Filing History:
1 out of 1,072 
1 out of 15,977 
Years Active: 2025
Title: Aina He: Innovator in Wnt Signaling Inhibition
Introduction
Aina He is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of Wnt signaling inhibition. Her innovative work has the potential to impact treatments for various diseases, including cancer.
Latest Patents
Aina He holds a patent titled "Compositions and methods for inhibiting Wnt signaling." This patent describes agents that bind to the lipid binding groove of Frizzled (FZD). In some embodiments, the agent is a fragment of TcdB corresponding to amino acids 1285-1804 of SEQ ID NO: 1. The binding of the agent to the lipid binding groove of FZD inhibits TcdB entry into cells and/or inhibits Wnt signaling. Additionally, methods for treating infections, such as Clostridium difficile infection (CDI), and methods for treating cancer are also provided in her patent. Aina He has 1 patent to her name.
Career Highlights
Throughout her career, Aina He has worked with notable organizations, including Children's Medical Center Corporation and the University of California. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Aina has collaborated with esteemed colleagues, including Liang Tao and Rongsheng Jin. These collaborations have further enriched her research and innovation in the field.
Conclusion
Aina He is a remarkable inventor whose work in inhibiting Wnt signaling has the potential to lead to significant advancements in medical treatments. Her contributions to the field are noteworthy and continue to inspire future innovations.